| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
and on Tumor Necrosis Factor for Its Antitumor Effects1
Department of Pathology and Laboratory Medicine, Hahnemann University, Philadelphia, Pennsylvania 19102
We reported previously that treatment of peritoneal cell (PC) cultures prepared from mice which harbor L5178Y lymphoma cells in a tumordormant state in their peritoneal cavity with interleukin 2 (HuIL-2) stimulated antitumor cytotoxic activity in both the nonadherent and adherent populations derived from such cultures. We report here that HuIL-2 induced the production of murine
interferon (MuIFN-
) in these PC cultures and required Lyt-1-, Lyt-2-, and L3T4-expressing lymphocytes to do so. HuIL-2 required and synergized with this induced MuIFN-
to stimulate cytotoxic activity in the nonadherent PC and the MuIFN-
itself stimulated cytotoxic activity in the adherent PC. Cyclosporin A prevented both the induction of MuIFN-
and the development of antitumor cytotoxic activity in HuIL-2-treated PC cultures. An add-back of exogenous MuIFN-
to HuIL-2-cyclosporin A-treated PC cultures and to the nonadherent subpopulation of such cultures, at a concentration which itself produced no antitumor effect, permitted HuIL-2 to induce its antitumor effect. We previously reported that MuIFN-
requires the action of murine tumor necrosis factor (MuTNF) to induce cytotoxic activity in PC cultures from tumor-dormant mice. We report here that HuIL-2 also requires the action of (MuTNF) to stimulate antitumor cytotoxic activity in PC cultures from tumor-dormant mice. These results indicate that HuIL-2 induces MuIFN-
and requires and synergizes with this MuIFN-
and with (MuTNF) to stimulate antitumor cytotoxic activity in PC cultures from tumor-dormant mice.
1 Supported by PHS Grant CA32577, awarded by the National Cancer Institute, HHHS, and by a grant from Hoffmann La Roche.
2 Current address: Second Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.
3 Current address: Beckman Instruments, 200 S. Kraemer Blvd., Brea, CA 92621.
4 To whom requests for reprints should be addressed, at Department of Pathology, Hahnemann University, Broad and Vine Streets, Philadelphia, PA 19102.
Received 9/ 7/88. Revised 7/13/89. Accepted 11/27/89.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |